Home » Topics » Disease categories and therapies » Infection

Infection
RSS

PathoGenesis and Chiron form antibiotic collaboration

Jan. 13, 2000

Macrolides synthesized at Pfizer reported to possess broad-spectrum antibacterial activity

Jan. 12, 2000

IL-15 potentiates the antiviral response of natural killer cells in vitro

Jan. 11, 2000

BioCryst updates influenza neuraminidase inhibitor program with R.W. Johnson

Jan. 10, 2000

Health Canada approves first pill to treat influenza

Jan. 10, 2000

Abbott's new ketolide ABT-773 will be codeveloped by Taisho

Jan. 10, 2000

NC-1175 possesses ATPase-targeted antifungal activity

Jan. 10, 2000

Merck describes novel penems with activity against resistant staphylococci

Jan. 10, 2000

CRL-1072 enhances antibiotic activity against MAI

Jan. 10, 2000

Japanese investigators prepare new agents for influenza

Jan. 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...